Harry Choi1, Domingo E Uceda1, Amit K Dey1, Nehal N Mehta2. 1. National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA. 2. National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA. nehal.mehta@nih.gov.
Abstract
PURPOSE OF REVIEW: Traditional risk models, such as the Framingham risk score, fail to capture the increased cardiovascular disease risk seen in patients with chronic inflammatory diseases. This review will cover imaging modalities and their emerging applications in assessing subclinical cardiovascular disease for both research and clinical care in patients with chronic inflammatory diseases. RECENT FINDINGS: Multiple imaging modalities have been studied to assess for subclinical cardiovascular disease via functional/physiologic, inflammatory, and anatomic assessment in patients with chronic inflammatory diseases. The use of imaging to evaluate subclinical cardiovascular disease in patients with chronic inflammatory diseases has the potential to capture early sub-clinical atherosclerosis, to improve risk stratification of future cardiovascular events, and to guide effective disease management.
PURPOSE OF REVIEW: Traditional risk models, such as the Framingham risk score, fail to capture the increased cardiovascular disease risk seen in patients with chronic inflammatory diseases. This review will cover imaging modalities and their emerging applications in assessing subclinical cardiovascular disease for both research and clinical care in patients with chronic inflammatory diseases. RECENT FINDINGS: Multiple imaging modalities have been studied to assess for subclinical cardiovascular disease via functional/physiologic, inflammatory, and anatomic assessment in patients with chronic inflammatory diseases. The use of imaging to evaluate subclinical cardiovascular disease in patients with chronic inflammatory diseases has the potential to capture early sub-clinical atherosclerosis, to improve risk stratification of future cardiovascular events, and to guide effective disease management.
Authors: S Laurent; P Boutouyrie; R Asmar; I Gautier; B Laloux; L Guize; P Ducimetiere; A Benetos Journal: Hypertension Date: 2001-05 Impact factor: 10.190
Authors: Matthias W Lorenz; Joseph F Polak; Maryam Kavousi; Ellisiv B Mathiesen; Henry Völzke; Tomi-Pekka Tuomainen; Dirk Sander; Matthieu Plichart; Alberico L Catapano; Christine M Robertson; Stefan Kiechl; Tatjana Rundek; Moïse Desvarieux; Lars Lind; Caroline Schmid; Pronabesh DasMahapatra; Lu Gao; Kathrin Ziegelbauer; Michiel L Bots; Simon G Thompson Journal: Lancet Date: 2012-04-27 Impact factor: 79.321
Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Nóra Bodnár; György Kerekes; Ildikó Seres; György Paragh; János Kappelmayer; Zsuzsanna Gyurcsik Némethné; Gyula Szegedi; Yehuda Shoenfeld; Sándor Sipka; Pál Soltész; Zoltán Szekanecz; Sándor Szántó Journal: J Rheumatol Date: 2011-01-15 Impact factor: 4.666
Authors: Aamer Sandoo; Jet J C S Veldhuijzen van Zanten; George S Metsios; Douglas Carroll; George D Kitas Journal: Rheumatology (Oxford) Date: 2011-09-16 Impact factor: 7.580
Authors: R Joannides; W E Haefeli; L Linder; V Richard; E H Bakkali; C Thuillez; T F Lüscher Journal: Circulation Date: 1995-03-01 Impact factor: 29.690
Authors: S Skeoch; P L Hubbard Cristinacce; H Williams; P Pemberton; D Xu; J Sun; J James; C Yuan; T Hatsukami; P D Hockings; M Y Alexander; J C Waterton; I N Bruce Journal: Sci Rep Date: 2017-04-11 Impact factor: 4.379